Nidus Exim Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.49 M
as on 24-10-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.64 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.40 Cr
as on 24-10-2024
- Revenue 122.29%
(FY 2023)
- Profit 405.02%
(FY 2023)
- Ebitda 246.00%
(FY 2023)
- Net Worth 179.32%
(FY 2023)
- Total Assets 6.85%
(FY 2023)
About Nidus Exim
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹5.64 Cr. The company has closed loans amounting to ₹4.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishwambhar Shedge and Supriya Shedge serve as directors at the Company.
- CIN/LLPIN
U51399PN2000PTC014771
- Company No.
014771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nidus Exim?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwambhar Shedge  | Director | 18-Apr-2000 | Current |
| Supriya Shedge | Director | 01-Jan-2013 | Current |
Financial Performance of Nidus Exim.
Nidus Exim Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.29% increase. The company also saw a substantial improvement in profitability, with a 405.02% increase in profit. The company's net worth Soared by an impressive increase of 179.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nidus Exim?
In 2023, Nidus Exim had a promoter holding of 97.93% and a public holding of 2.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nidus Healthcare Private LimitedActive 17 years 2 monthsVishwambhar Shedge and Supriya Shedge are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jul 2024 | ₹4.80 M | Open |
Others Creation Date: 23 Jan 2024 | ₹7.52 M | Open |
Yes Bank Limited Creation Date: 03 Jan 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Nidus Exim?
Unlock and access historical data on people associated with Nidus Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nidus Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nidus Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
